Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 2.942
-0.238 (-7.48%)
May 22, 2026, 5:29 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 731.42 million as of May 22, 2026. Its market cap has increased by 82.96% in one year.
Market Cap
731.42M
Enterprise Value
473.38M
Revenue
317.21M
Ranking
n/a
PE Ratio
4.61
Stock Price
2.94
Market Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 731.42M, an increase of 506.71%. That is a compound annual growth rate of 17.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 731.42M | -29.70% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.35B |
| Xspray Pharma AB | 1.17B |
| Medivir AB | 1.02B |
| SynAct Pharma AB | 784.02M |
| Infant Bacterial Therapeutics AB | 749.01M |
| FluoGuide | 678.50M |
| Oncopeptides AB | 646.29M |
| Corline Biomedical AB | 475.62M |